Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Progress in 11β-HSD1 inhibitors for the treatment of metabolic diseases: A comprehensive guide to their chemical structure diversity in drug development
Chuanxin Zhong, Shengzheng Wang, Lei Dang, et al.
European Journal of Medicinal Chemistry (2020) Vol. 191, pp. 112134-112134
Closed Access | Times Cited: 23

Showing 23 citing articles:

The Role and Mechanism of Oxidative Stress and Nuclear Receptors in the Development of NAFLD
Ting Hong, Yiyan Chen, M Kellis, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 67
Advancing targeted protein degradation for metabolic diseases therapy
Qianqian Zhou, Haitao Xiao, Fan Yang, et al.
Pharmacological Research (2022) Vol. 188, pp. 106627-106627
Open Access | Times Cited: 34
Glucocorticoid activation by HSD11B1 limits T cell-driven interferon signaling and response to PD-1 blockade in melanoma
Luiza Martins Nascentes Melo, Dayana Herrera-Rios, Daniel Hinze, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 4, pp. e004150-e004150
Open Access | Times Cited: 16
11β-hydroxysteroid dehydrogenases: A growing multi-tasking family
Elise P. Gómez-Sánchez, Celso E. Gómez-Sánchez
Molecular and Cellular Endocrinology (2021) Vol. 526, pp. 111210-111210
Open Access | Times Cited: 40
Inhibition of 11β‐Hydroxysteroid dehydrogenase‐1 with AZD4017 in patients with nonalcoholic steatohepatitis or nonalcoholic fatty liver disease: A randomized, double‐blind, placebo‐controlled, phase II study
Yogesh Yadav, Kelly T. Dunagan, Rachita Khot, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 5, pp. 881-890
Open Access | Times Cited: 22
Role of 11β-hydroxysteroid dehydrogenase type 1 inhibition in the antiobesity effect of J2H-1702 on adipocytes and a high-fat diet-induced NASH model
Da Young Lee, Kiwon Jung, J.H. Lee, et al.
European Journal of Pharmacology (2025) Vol. 989, pp. 177272-177272
Closed Access
Impact of Red Yeast Rice on Metabolic Diseases: A Review of Possible Mechanisms of Action
Hu Ju, Jin Wang, Qingxia Gan, et al.
Journal of Agricultural and Food Chemistry (2020) Vol. 68, Iss. 39, pp. 10441-10455
Closed Access | Times Cited: 32
Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework
Xi Xiong, Haijun He, Qianqian Ye, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 30, Iss. 2
Open Access | Times Cited: 9
Equisetin is an anti-obesity candidate through targeting 11β-HSD1
Zhenlu Xu, Dongyun Liu, Dong Liu, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 12, Iss. 5, pp. 2358-2373
Open Access | Times Cited: 12
Activation of endogenous glucocorticoids by HSD11B1 inhibits the antitumor immune response in renal cancer
Hélène Poinot, Eloïse Dupuychaffray, Grégoire Arnoux, et al.
OncoImmunology (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 6
Identify the Novel Potential 11β-HSD1 Inhibitors Based on Deep Learning, Molecular Modelling and Activity Evaluation
Xiaodie Chen, Xingyu Liu, Lu Zhang, et al.
(2024)
Closed Access | Times Cited: 1
Crystal structure, antioxidant evaluation, theoretical investigation: DFT, docking, and ADMET properties evaluation of 1-[(E)-2-(2-fluorophenyl) diazan-1-ylidene] naphthalen-2(1H)-one
Hibet Errahmane Meroua Akkache, Noudjoud Hamdouni, Sabah Kellou, et al.
Journal of Molecular Structure (2024) Vol. 1317, pp. 139090-139090
Closed Access | Times Cited: 1
Hypercortisolism and altered glucose homeostasis in obese patients in the pre‐bariatric surgery assessment
Emanuele Muraca, Stefano Ciardullo, Silvia Perra, et al.
Diabetes/Metabolism Research and Reviews (2020) Vol. 37, Iss. 3
Open Access | Times Cited: 6
Prominent and emerging anti-diabetic molecular targets
Faezeh Almasi, Fatemeh Mohammadipanah
Journal of drug targeting (2020) Vol. 29, Iss. 5, pp. 491-506
Closed Access | Times Cited: 6
Molecules and targets of antidiabetic interest
Kavishankar Gawli, Kavya Sritha Bojja
Phytomedicine Plus (2023) Vol. 4, Iss. 1, pp. 100506-100506
Open Access | Times Cited: 2
Role of corticosteroids in skin physiology and therapeutic potential of an 11β‐HSD1 inhibitor: A review
Larissa Hall, Robert A. de J. Hart
International Journal of Dermatology (2023) Vol. 63, Iss. 4, pp. 443-454
Open Access | Times Cited: 2
Targeting osteoblastic 11β-HSD1 to combat high-fat diet-induced bone loss and obesity
Chuanxin Zhong, Nanxi Li, Shengzheng Wang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access
Electrospun 11β-HSD1 Inhibitor-Loaded Scaffolds for Accelerating Diabetic Ulcer Healing
Xiaofeng Ding, Heyan Huang, Y. Chen, et al.
ACS Applied Bio Materials (2024)
Closed Access
Employing Molecular Docking Calculations for the Design of Alkyl (2-Alcoxy-2-Hydroxypropanoyl)-L-Tryptophanate Derivatives as Potential Inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1 (11β-HSD1)
Diego Quiroga
Reactions (2023) Vol. 4, Iss. 1, pp. 108-116
Open Access | Times Cited: 1
Identification of a human blood biomarker of pharmacological 11β‐hydroxysteroid dehydrogenase 1 inhibition
Cristina Gómez, Zerin Alimajstorovic, Nantia Othonos, et al.
British Journal of Pharmacology (2023) Vol. 181, Iss. 5, pp. 698-711
Open Access | Times Cited: 1
Editorial: Liver hypercortisolism as a potential target for MASH treatment
Stephen A. Harrison, Julie Dubourg
Alimentary Pharmacology & Therapeutics (2023) Vol. 58, Iss. 11-12, pp. 1238-1239
Open Access | Times Cited: 1
Identification of a human blood biomarker of pharmacological 11β-hydroxysteroid dehydrogenase 1 inhibition
Cristina Gómez Castella, Zerin Alimajstorovic, Nantia Othonos, et al.
Authorea (Authorea) (2023)
Open Access
Discovery of a novel 2-spiroproline steroid mimetic scaffold for the potent inhibition of 11β-HSD1
David Burns, Chunhong He, Yunlong Li, et al.
Bioorganic & Medicinal Chemistry Letters (2022) Vol. 73, pp. 128884-128884
Closed Access
Page 1

Scroll to top